Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:56 PM
Ignite Modification Date:
2025-12-24 @ 5:56 PM
NCT ID:
NCT05806268
Eligibility Criteria:
Inclusion criteria
* Diagnosis of melanoma (ICD-9 172.x \& ICD-10 C43 or D03x)
* Pathologic stage III (unresectable) or IV at initial diagnosis on or after 01 January 2011
* 1L treatment with enco/bini or dab/tram on or after 01 June 2018
* Evidence of a BRAF test
* Evidence of a BRAF-positive result prior to or up to 30 days after 1L therapy initiation
* At least 18 years of age at the time of initiation of 1L treatment Exclusion criteria
* Documented receipt of a clinical trial treatment for cancer at any time on or after September 2015
* Diagnosis of a second primary cancer or secondary cancer following initiation of 1L metastatic melanoma (MM) treatment
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05806268
Study Brief:
Protocol Section:
NCT05806268